EQA Program 2022
Labquality’s external quality assessment program (EQAS) is aimed at medical laboratories and point-of-care testing sites. The program includes more than 170 clinically relevant external quality assessment schemes and it is fully compliant with ISO15189 standard requirements.
Subscription for 2022 is open
Please subscribe to the 2022 EQA programs before the end of November 2021 to ensure your participation in all needed EQA rounds. You can renew your subscription by contacting our local partner in your country. Direct customers of Labquality can renew their subscriptions on LabScala. If you need more information, please contact our customer service info@labquality.fi.
Changes in the 2022 program:
New schemes and products
– 2281 Interleukin-6
– 5851 Francisella tularensis, antibodies
– 5651 CMV and EBV, nucleic acid detection, quantitative
– 2753 Gastric biomarkers
– 2526 Ketones (beta-hydroxybutyrate), POCT
– 5562 Multiple Respiratory Virus nucleic acid detection
– 7807 Preanalytics, Pneumatic Sample Transport
Discontinued schemes and products
– 4238 Leucocyte differential count, 5-part, automated: Abacus
– 2733 Erythrocyte sedimentation rate, iSED
Planned pilot schemes
Information about pilot contents and schedules will be announced later. Pilot schemes are EQA schemes under our product development.
All changes are listed in the Product Catalogue 2022 on page 5.
Please download the catalogue from the button below.
